Understanding Depression Treatment
The conversation delves into the evolution of depression treatment, highlighting the monoamine hypothesis, which suggests that deficiencies in neurotransmitters like serotonin and dopamine contribute to depression. Despite the widespread use of medications like Prozac and Zoloft, only about 40% of individuals experience relief, with many facing uncomfortable side effects. This raises critical questions about the efficacy and accessibility of current treatment options for those suffering from depression.In this clip
From this podcast
Huberman Lab
Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast
Related Questions